Outcomes in perioperative care

Current Opinion in Anaesthesiology

Volumn 23, Issue 2, 2010, Pages 201-208

  Mantz, Jean ^a,b   Dahmani, Souhayl ^b   Paugam Burtz, Catherine ^a  

^a BEAUJON HOSPITAL   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Blockers; Anesthesia; Elderly; Outcomes; Perioperative care

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; STEROID; THIENOPYRIDINE DERIVATIVE; TROPONIN I;

ADVERSE OUTCOME; ANESTHESIST; CEREBROVASCULAR ACCIDENT; CHECKLIST; CLINICAL DECISION MAKING; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; DELIRIUM; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; GLYCEMIC CONTROL; HEART PROTECTION; HEMODYNAMIC MONITORING; HUMAN; INSULIN TREATMENT; INTENSIVE CARE; INTERDISCIPLINARY COMMUNICATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STENT THROMBOSIS; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL STRESS;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHECKLIST; COGNITION DISORDERS; ERYTHROCYTE TRANSFUSION; HEART DISEASES; HEMODYNAMICS; HUMANS; MONITORING, PHYSIOLOGIC; OPERATING ROOMS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; STRESS, PHYSIOLOGICAL; TREATMENT OUTCOME;

EID: 77952157393     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328336aeef     Document Type: Review

References (51)

1. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce •• morbidity and mortality in a global population. N Engl J Med 2009;360:491-499. This is a pivotal study that demonstrates the beneficial impact on patient survival of implementing a surgical safety checklist in the operating room. This procedure should have a major impact on routine anesthesia and surgery in the world.
2. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992;326:281-286.
3. Lingard L, Regehr G, Orser B, et al. Evaluation of a preoperative checklist and team briefing among surgeons, nurses and anesthesiologists to reduce failure in communication. Arch Surg 2008;143:12-18.
4. Longrois D, Agavriloaia M, Devaux Y, Mertes M. Comments on methodological • problems related to the use of biomarkers in clinical practice and research. Ann Fr Anesth Reanim 2009;28:473-481. An interesting comment on the interest and limitations of the use of biomarkers related to perioperative outcome (in French, summary in English).
5. Ryding A D S, Kumar S, Worthington AM, Burgess D. Prognostic value of brain • natriuretic peptide in noncardiac surgery. A meta-analysis. Anesthesiology 2009;111:311-319. In this meta-analysis, preoperative measurement of plasma BNP predicts mortality and major adverse cardiovascular events after noncardiac surgery.
6. Lasocki S, Provenchere S, Benessiano J, et al. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesthesiology 2002;97:405-411.
7. Fellahi JL, Hanouz JL, le Manach Y, et al. Simultaneous measurement of • cardiac troponin I, B-natriuretic peptide, and C-reactive protein for the prediction of long term cardiac outcome after cardiac surgery. Anesthesiology 2009;111:250-257. This study shows that simultaneous measurement of postoperative cTropI, B-type natriuretic peptide and C-reactive protein improves the risk assessment of longterm adverse cardiac outcome after cardiac surgery.
8. Deveraux PJ. Can attenuation of the perioperative stress response prevent • intermediate or long-term cardiovascular outcomes among patients undergoing noncardiac surgery? Anesthesiology 2009;111:223-226. An interesting comment on the issues raised by the use of β-blockers in the perioperative period by the senior author of the POISE trial.
9. Poldermans D, Schouten O, van Lier F, et al. Perioperative stroke and ß- • blockade. Anesthesiology 2009;111:940-945. An interesting review of the ongoing facts and hypotheses related to perioperative β-blockade in patients at risk for postoperative cardiac events.
10. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended release metoprolol •• succinate in patients undergoing noncardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-1847. The largest prospective, randomized trial that examined the efficacy and safety of perioperative β-blockade on outcome in patients at risk of atherosclerotic disease undergoing noncardiac surgery. Metoprolol was given 2-4 h before surgery and continued up to day 30. Patients taking metoprolol had fewer postoperative major cardiac adverse events. However, the overall mortality rate and incidence of stroke was higher in patients treated by metoprolol.
11. Bangalore S, Wetterslev J, Pranesth S, et al. Perioperative beta-blockers in patients having noncardiac surgery: a meta-analysis. Lancet 2008;372:1962-1976.
12. Van Klei WA, Bryson GL, Yang H, Forster AJ. Effect of beta-blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty. Anesthesiology 2009;111:717-724.
13. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol andfluvastatinforthe •• reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial. Ann Surg 2009;249:941-946. In this randomized controlled trial, it is shown that preoperative statins combined with β-blockers reduce cardiovascular major complications and stroke in noncardiac surgery. It is difficult to imagine any additional trial without patients on perioperative therapy with statins.
14. Katznelson R, Djaiani GN, Borger MA, et al. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology 2009;110:67-73.
15. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on • perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Anesth Analg 2008;106:685-712. An update of perioperative cardiovascular evaluation before noncardiac surgery.
16. Caplan RA, Connis RT, Nickinovich DG, et al. Practice alert for the perioperative management of patients with coronary stents. Anesthesiology 2009;110:22-23.
17. Nutall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008;109:588-595.
18. Rabbitts JA, Nutall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109:596-604.
19. Rhee SJ, Yun KH, Lee SR, et al. Drug-eluting stents thrombosis during perioperative period. Int Heart J 2008;49:135-142.
20. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007;99:316-328.
21. Mega JL, Close SL, Wiviott SD, et al. Cytochrome P450 polymorphisms and • response to clopidogrel. N Engl J Med 2009;360:354-362. This study nicely shows genetic variability in response to clopidogrel in the general population.
22. Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response • to clopidogrel and cardiovascular events. N Engl J Med 2009;360:363-375. This study nicely shows genetic variability in response to clopidogrel in the general population.
23. Eisenberg MJ, Richard PR, Libersan D, Filion KB. Safety of short-term • discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009;119:1634-1642. This meta-analysis shows that, in patients with dual antiplatelet therapy in whom clopidogrel has been discontinued before surgery, maintenance of aspirin significantly decreases the risk of postoperative short-term thrombotic event. This option may represent the best compromise in this frequently encountered clinical situation.
24. Cannesson M, Musard H, Desebbe O, et al. The ability of stroke volume variations obtained with Vigileo/Flotrac system to monitor fluid responsiveness in mechanically ventilated patients. Anesth Analg 2009;108:513-517.
25. Biais M, Nouette-Gaulain K, Quinart A, et al. Uncalibrated stroke volume variations are able to predict the hemodynamic effects of positive end expiratory pressure in patients with acute lung injury or acute respiratory distress syndrome after liver transplantation. Anesthesiology 2009;111:855-862.
26. Biais M, Nouette-Gaulain K, Cottenceau V, et al. Uncalibrated pulse contourderived stroke volume variation predicts fluid responsiveness in mechanically ventilated patients undergoing liver transplantation. Br J Anaesth 2008;101:761-768.
27. Sanders RD, Maze M. Does correcting the numbers improve long-term • outcome? Anesthesiology 2009;111:475-477. An interesting, sometimes provocative, critical editorial of the clinical use of parameters obtained from multimodal monitoring in the operating room.
28. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-2552.
29. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007;116:471-479. (Pubitemid 47450255)
30. Spahn D, Moch H, Hofmann A, Isbister JP. Patient blood management. The pragmatic solution for the problems with blood transfusion. Anesthesiology 2008;109:951-953.
31. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: • a systematic review of the literature. Crit Care Med 2008;36:2667-2674. An interesting review on the adverse effects of transfusion in ICU patients.
32. Sarani B, Dunkman WJ, Dean L, et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008;36:1114-1118.
33. Lenoir B, Merckx P, Paugam-Burtz C, et al. Individual probability of allogeneic • erythrocyte transfusion in elective spine surgery. Anesthesiology 2009;110:1050-1060. Derivation and validation of a model predictive of red cell transfusion in spinal surgery. The detailed report of the methods used to derive and validate a clinical score may be useful.
34. Atzil S, Asral M, Glasner A, et al. Blood transfusion promotes cancer • progression: a critical role for aged erythrocytes. Anesthesiology 2008;109:989-997. An elegant experimental study in which the role of aged erythrocytes (neither platelets nor white cells) in facilitating lung tumor implantation is demonstrated. This adds a piece of original information to the adverse effects of allogeneic or autologous red cell transfusion.
35. Surgenor SD, Kramer RS, Olmstead EM, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009;108:1741-1746.
36. Weightmann WM, Gibbs NM, Sheminant MR, et al. Moderate exposure to allogeneic blood products is not associated with reduced long-term survival after surgery for coronary artery disease. Anesthesiology 2009;111:327-333.
37. De Saint Maurice G, Pequignot F, Auroy Y, et al. Patient blood management • and transfusion. Anesthesiology 2009;111:444-445. A letter in response to the editorial by Spahn et al. (ref. [30]), in which attention is drawn toward the dangers of underestimating and mistreating hemorrhage intraoperatively or postoperatively.
38. Lienhart A, Auroy Y, Pequignot F, et al. Survey of anesthesia-related mortality in France. Anesthesiology 2006;105:1087-1097.
39. Blasi-Ibanez A, Hirose R, Feiner J, et al. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology 2009;110:333-341.
40. -1 range in mechanically ventilated patients in the ICU.
41. Lipshutz AK, Gropper MA. Perioperative glycemic control. An evidence-based • review. Anesthesiology 2009;110:408-421. An interesting, comprehensive review of the data on tight glucose control in the perioperative context.
42. Fahy BG, Sheehy AM, Coursin DB. Perioperative glucose control: what is enough? Anesthesiology 2009;110:204-206.
43. Monk TG, Weldon BC, Garvan CW, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008;108:18-30.
44. Price CC, Gravan CW, Monk TG. Type and severity of cognitive decline in • older adults after noncardiac surgery. Anesthesiology 2008;108:8-17. An interesting description of the disabilities associated with postoperative cognitive dysfunction in elderly patients.
45. Steinmetz J, Christensen KB, Lund T, et al. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology 2009;110:548-555.
46. Yocum GT, Gaudet JG, Teverbaugh LA, et al. Neurocognitive performances in hypertensive patients after spine surgery. Anesthesiology 2009;110:254-261.
47. Zhen Y, Dong Y, Wu X, et al. Nitrous oxide plus isoflurane induces apotosis and increases ß-amyloid protein levels. Anesthesiology 2009;111:741-752.
48. Pasternak JJ, McGregor DG, Lanier WL, et al. Effects of nitrous oxide use on long-term neurologic outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery. Anesthesiology 2009;110:563-573.
49. Hocker T, Stapelfeldt C, Leiendecker J, et al. Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofol anesthesia for major noncardiac surgery. A double-blind, randomized, controlled, pilot study. Anesthesiology 2009;110:1068-1076.
50. Avidan MS, Searlman AC, Martha S, et al. Long-term cognitive dysfunction decline in older subjects was not attributable to noncardiac surgery or major illness. Anesthesiology 2009;111:964-970.
51. Dyspersyn G, Touitou Y, Coste O, et al. Desynchronization of daily rest-activity • rhythm in the days following light propofol anesthesia for colonoscopy. Clin Pharmacol Ther 2009;85:51-55. The first clear-cut demonstration of the role of propofol anesthesia in inducing major changes in daily rest-activity rhythm in patients undergoing anesthesia.